Amicus Therapeutics Announces Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
Amicus Therapeutics (FOLD) Prices 16.98M Common Secondary Offering at $13.25/Share
June 12, 2015 6:17 AM EDTAmicus Therapeutics (NASDAQ: FOLD) announced the pricing of an underwritten offering of 16,981,132 shares of its common stock at $13.25 per share. The gross proceeds from the offering to Amicus are expected to be $225 million, before deducting underwriting discounts and commissions and estimated offering expenses... More
Amicus Therapeutics (FOLD) Announces $150M Common Stock Offering
June 10, 2015 4:02 PM EDTAmicus Therapeutics (NASDAQ: FOLD) announced it has commenced a $150 million underwritten public offering of its common stock. J.P. Morgan Securities LLC and Goldman, Sachs & Co. are acting as joint book-running managers for the proposed offering. Cowen and Company, LLC is acting as... More
